This Solicitation opportunity from Department Of Defense was posted on May 6, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
NORETHINDRONE AND E
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract specifies the procurement of Norethindrone and Ethinyl Estradiol Tablets, USP, a combined oral contraceptive regulated by the FDA, in a rigidly defined packaging configuration: each cycle consists of 28 tablets—seven tablets containing 0.5 mg norethindrone and 35 mcg ethinyl estradiol, seven tablets with 0.75 mg norethindrone and 35 mcg ethinyl estradiol, seven tablets with 1 mg norethindrone and 25 mcg ethinyl estradiol, and seven inert tablets—with six such cycles packaged as a single unit of issue, totaling 168 tablets per package. The product must maintain a minimum shelf life of 36 months from manufacture, with no more than five months allowed between manufacturing and government delivery, requiring that at least 31 months remain prior to delivery. Packaging and labeling must strictly comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must ensure protection against damage during transport. Each unit must be sealed in an appropriate container, packed in commercial shipping containers capable of safe delivery via common carrier at the lowest cost to the designated destination. The item is sourced from TEVA PHARMACEUTICALS USA, INC., identified by NDC 00555-9012-58 and NSN 6505-01-506-2659, with a required delivery of three packages within five business days under FOB destination terms and zero tolerance for quantity variance. All packaging and marking must adhere to DLA’s Medical Marking Standard No. 1, accessible through official DLA channels, and the product must be stored at 25°C (77°F) with allowable excursions between 15°C and 30°C (59°F to 86°F). The solicitation number is SPE2DP-26-T-3280, issued by the Department of Defense’s Medical Supply Chain, with a response deadline of May 12, 2026, and a primary point of contact at DLA for inquiries. The contract mandates compliance with all applicable DLA technical and quality requirements referenced through R and I numbers in the DLA Master List and includes provisions for covered defense information, requiring strict adherence to labeling, packaging, and delivery protocols for military medical supply chains.
General Info
Agency
NAICS
Place of Performance
UNIT 3865 BOX, APO, AE, 09126-3865, USASet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Submission Closed
Organization & Contact Information
Full Description
NORETHINDRONE AND ETHINYL ESTRADIOL TABLETS,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
7 TABLETS WITH 0.5 MG & 35 MCG; 7 TABLETS WITH 0.75 MG & 35 MCG AND 7
TABLETS WITH 1 MG AND 25 MCG OF ACTIVE INGREDIENT PLUS 7 INERT TABLETS
28 TABLETS PER CYCLE, 6 CYCLES PER PKG UNIT OF ISSUE "PACKAGE" (6
CYCLES OF 28 TABLETS) SHALL HAVE A SHELF LIFE OF 36 MONTHS. NOT LESS
THAN 31 MONTHS SHALL HAVE ELAPSED FROM DATE OF MANUFACTURE TO DATE OF
DELIVERY TO THE GOVERNMENT.. LABELING AND MARKING MUST IN ACCORDANCE
WITH MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY 2013. STORE AT
25°C (77°F); EXCURSIONS PERMITTED TO 15°#30°C (59°#86°F)
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
1 PG = 168 TT
1 PG = 168 TT
This device or drug is regulated by the FDA.
SPE2DP-26-T-3280
SECTION B
Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
. SHALL BE MARKED IAW THE LATEST EDITION OF THE MEDICAL MARKING STANDARD NO. 1. MMS NO. 1 IS AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC00555-9012-58
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016658215 0001 PG 3.000
NSN/MATERIAL:6505015062659
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-506-2659 Quantity: 3 PG Purchase Request: 7015321235QTY: 3 Delivery: 5 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS